Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03281928 · ClinicalTrials.gov registry record · NA
Effect of Dietary Sodium and Potassium Citrate on Renal Mineral Handling
A NA study, sponsored by University of Chicago.
- Terminated
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT03281928: Clinical Trial NA study, sponsored by University of Chicago.
NCT03281928 is a NA study that was terminated before completion, run by University of Chicago. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03281928, a NA study, was terminated before completion, sponsored by University of Chicago.
- TERMINATED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
This study intends to characterize the affect of sodium and potassium citrate in the diet on renal function.
Primary Outcome
Amount of calcium in the urine will be measured
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Sodium and Potassium Citrate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2017-10-01 |
| Est. Completion | 2022-11-15 |
| Phase | NA |
Why NCT03281928 stopped before completion
NCT03281928 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03281928 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03281928 about?
NCT03281928 is a clinical study titled "Effect of Dietary Sodium and Potassium Citrate on Renal Mineral Handling". This study intends to characterize the affect of sodium and potassium citrate in the diet on renal function.
What is the current status of trial NCT03281928?
This trial is currently terminated. It is a NA study. The enrollment target is 30 participants. The study started on 2017-10-01. Estimated completion is 2022-11-15.
What interventions are being tested in trial NCT03281928?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Sodium and Potassium Citrate (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03281928?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03281928's enrollment target sits among peer trials
30 1593rd of 2000 higher than 299 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI